Galaxy Surfactants Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
- April 12, 2026
- Posted by: sachet
- Category: News
Galaxy Surfactants (NSE: GALAXYSURF) is preparing to announce its Q4 FY26 financial results for the period ended March 31, 2026. The board of directors is scheduled to meet on May 2026 (Expected) to approve the audited statements and consider a final dividend recommendation. With the stock trading at Rs 2,800 — against a 52-week high of Rs 3,800 and a 1-year return of -18% — the Q4 FY26 results will be a pivotal event for investors.
Analyst estimates for Q4 FY26 revenue stand at Rs 1,120-1,210 Cr, with PAT expectations of Rs 90-105 Cr and margin projections of EBITDA 12-14%. This article covers the Galaxy Surfactants Q4 results 2026 date, earnings estimates, five key performance factors, five risks, analyst ratings, and the most commonly searched investor questions.
Galaxy Surfactants Q4 Results 2026 Date
Get free investment predictions and live Q4 result alerts on Univest.
Galaxy Surfactants has scheduled its Q4 FY26 results for May 2026 (Expected). Here is the broader Q4 FY26 earnings calendar:
| Company | Results Date | Article |
| TCS | April 9, 2026 | Preview on Univest |
| Infosys | April 23, 2026 | Preview on Univest |
| Galaxy Surfactants | May 2026 (Expected) | This article |
Why This Quarter Matters
Galaxy Surfactants enters Q4 FY26 with expectations of 8-12% YoY revenue growth. Q4 is the final quarter of FY26 — it determines full-year performance, sets FY27 estimate baselines, and triggers final dividend announcements. At a 1-year return of -18%, this quarter’s results and FY27 guidance will be critical in determining whether the stock can sustain recovery momentum.
Galaxy Surfactants Q4 FY26 Earnings Estimates

Access premium SEBI-registered research on Univest.
| Metric | Q3 FY26 Actual | Q4 FY26 Estimate | Driver |
| Revenue | Rs 1,052 Cr | Rs 1,120-1,210 Cr | Volume + pricing |
| PAT | Rs 82 Cr | Rs 90-105 Cr | Operating leverage |
| Margin | EBITDA 12.4% | EBITDA 12-14% | Cost control |
| Key Growth Metric | Q3 trend | 8-12% YoY revenue growth | Management execution |
| Dividend Estimate | — | Rs 16-22 per share | Board recommendation |
A positive surprise on any two of the four key parameters — revenue, margin, guidance, and dividend — could drive a meaningful post-results re-rating.
Screen Galaxy Surfactants fundamentals on Univest Screener.
5 Key Factors That Will Drive Galaxy Surfactants Q4 FY26 Performance
Revenue Momentum
Analysts expect Rs 1,120-1,210 Cr in Q4 FY26 revenue versus Rs 1,052 Cr in Q3. Q4 is seasonally important for the Chemicals/FMCG sector. The ability to convert the pipeline into recognised revenue will be the first performance test investors focus on when results are declared.
Margin Trajectory
Q4 FY26 margin expectations are EBITDA 12-14% versus EBITDA 12.4% in Q3. Input cost trends, employee expenses, and pricing power will determine whether the company can sustain or improve on Q3 levels. Any margin beat would be a significant positive catalyst for the stock.
PAT Quality
Net profit is estimated at Rs 90-105 Cr. Investors will closely assess whether PAT is driven by operational improvement or non-recurring items. A clean, recurring profit print is most positively received by institutional investors tracking the stock.
Management Guidance for FY27
The most consequential output will be FY27 guidance — revenue growth bands, margin targets, and capex plans. In the current global macro environment, credible and specific FY27 guidance will be valued more than usual by the market.
Dividend Declaration
Galaxy Surfactants is expected to consider a final dividend of Rs 16-22 per share. The quantum signals management’s confidence in free cash flow generation and sets expectations for FY27 capital allocation strategy.
5 Risks to Watch in Galaxy Surfactants Q4 FY26
US Tariff and Macro Headwinds
The 26% US reciprocal tariff on Indian goods has created macro uncertainty across all Indian equities. For Galaxy Surfactants, indirect impacts include FII outflows and potential earnings estimate cuts if global demand slows. Progress in India-US trade negotiations remains the most important macro catalyst.
Earnings Miss Risk
If Galaxy Surfactants’s Q4 FY26 results miss estimates, the stock could correct sharply regardless of longer-term fundamentals. Investors should monitor revenue versus the Rs 1,120-1,210 Cr estimate and PAT versus Rs 90-105 Cr as the two primary watchpoints.
FY27 Guidance Below Consensus
If FY27 guidance falls below Street expectations, the stock may decline even if Q4 numbers are in line. In the current environment, forward guidance carries more weight than the reported quarter.
FII Outflow Continuation
FIIs sold Rs 22,000 crore in Indian equities in a single week following the tariff announcement. Continued selling pressure would create headwinds for Galaxy Surfactants regardless of company-specific fundamentals.
Sector Regulatory Risk
The Chemicals/FMCG sector faces evolving regulatory frameworks. Any policy changes that increase compliance costs or alter competitive dynamics could affect Galaxy Surfactants’s profitability beyond current consensus models.
Galaxy Surfactants Share Price and Analyst Ratings

Galaxy Surfactants is trading at Rs 2,800 as of early April 2026, against a 52-week high of Rs 3,800 and a 52-week low of Rs 2,300. Market cap stands at Rs 7,900 Cr. The 1-year return of -18% reflects sector headwinds alongside company-specific factors.
| Brokerage | Rating | Target Price | Thesis |
| MOFSL | Buy | Rs 3,500 | Surfactants for FMCG HUL/P&G; global |
| YES Securities | Buy | Rs 3,400 | Egypt + US capacity expansion |
| JM Financial | Add | Rs 3,250 | Volume growth as FMCG demand rises |
| Emkay | Buy | Rs 3,300 | Niche chemical; specialty over commodity |
Download the Univest iOS App or Univest Android App to track Galaxy Surfactants’s live price and receive real-time Q4 result alerts.
Conclusion
Galaxy Surfactants Q4 FY26 results on May 2026 (Expected) will be a key event for investors monitoring the Chemicals/FMCG sector. Analysts project PAT of Rs 90-105 Cr and revenue of Rs 1,120-1,210 Cr. At a CMP of Rs 2,800 and analyst targets ranging from Rs 3,300 to Rs 3,500, the stock offers meaningful risk-reward for informed investors. FY27 guidance will be the most critical post-results catalyst.
For more Q4 FY26 previews across sectors, visit Univest Blogs.
Frequently Asked Questions
What is the Galaxy Surfactants Q4 results 2026 date?
The Galaxy Surfactants Q4 results 2026 date is May 2026 (Expected). The board will meet to approve audited Q4 FY26 financials and consider a dividend recommendation for FY26.
What is the Galaxy Surfactants Q4 FY26 PAT estimate?
Analysts estimate Galaxy Surfactants Q4 FY26 PAT at Rs 90-105 Cr, based on revenue of Rs 1,120-1,210 Cr and margin of EBITDA 12-14%. Actual results may differ from consensus estimates.
What is Galaxy Surfactants’s share price ahead of Q4 results?
Galaxy Surfactants is trading at Rs 2,800. The 52-week high is Rs 3,800 and low is Rs 2,300. The 1-year return is -18% and market cap is Rs 7,900 Cr.
Will Galaxy Surfactants declare a dividend in Q4 FY26?
Galaxy Surfactants is expected to consider a final dividend of Rs 16-22 per share at the Q4 FY26 board meeting on May 2026 (Expected).
Which analysts have a Buy rating on Galaxy Surfactants?
MOFSL (Buy, Rs 3,500), YES Securities (Buy, Rs 3,400), JM Financial (Add, Rs 3,250), Emkay (Buy, Rs 3,300) have positive ratings heading into Q4 FY26.
What were Galaxy Surfactants Q3 FY26 results?
Galaxy Surfactants reported Q3 FY26 revenue of Rs 1,052 Cr and PAT of Rs 82 Cr, with margin at EBITDA 12.4%. These form the baseline for Q4 FY26 consensus estimates.
When do Infosys and TCS announce Q4 results 2026?
TCS declared Q4 FY26 results on April 9, 2026. Read the TCS Q4 Results 2026 preview on Univest Blogs. Infosys Q4 FY26 results are scheduled for April 23, 2026. Read the Infosys Q4 Results 2026 preview on Univest Blogs.
Is Galaxy Surfactants a good investment ahead of Q4 results?
This depends on your risk appetite and portfolio context. Galaxy Surfactants has compelling long-term factors alongside genuine near-term risks. Consult a SEBI-registered financial advisor before making any investment decision.
Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.
Recent Article
UPL Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Zee Entertainment Enterprises Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Sun TV Network Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Sapphire Foods India Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Metro Brands Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook